Back to results
US 9,040,701 B2Granted
Apaf-1 inhibitor compounds
AssigneeLaboratorios Salvat, S.A.
InventorsÁngel Messeguer Peypoch, Alejandra Moure Fernández, Daniel González Pinacho, Isabel Masip Masip, Enrique Pérez Payá, Natividad García Villar, Ester Monlleó Mas, Juanlo Catena Ruiz
Life of this patent
Estimating the term…
Abstract
Derivatives of 2,5-piperazinedione of formula (I) are apoptotic peptidase activating factor 1 (Apaf-1) inhibitors, therefore they are useful as active pharmaceutical ingredients for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase of apoptosis.
Claims13
A compound of formula (I)
- or pharmaceutically acceptable salts thereof, wherein:
- R1 is —(CH2)0-3-aryl,
- R2 is selected from —C1-5 alkyl, —C2-5 alkenyl, —(CH2)0-3-cycloalkyl, —(CH2)1-3-heterocycle, —(CH2)0-3-aryl, —(CH2)0-3-heteroaryl, —(CH2)1-2—CH(aryl)2, —(CH2)1-2—CH(aryl)(heteroaryl) and —(CH2)1-2—CH(heteroaryl)2,
- R3 is selected from —H, —C1-5 alkyl, —C2-5 alkenyl, —(CH2)0-3-cycloalkyl, —(CH2)1-3-heterocycle, —(CH2)1-3-aryl, —(CH2)1-3-heteroaryl, —(CH2)1-3—CONR5R6, —(CH2)1-2—CH(aryl)2, —(CH2)1-2—CH(aryl)(heteroaryl) and —(CH2)1-2—CH(heteroaryl)2,
- R4 is selected from —H, —C1-5 alkyl, —(CHR7)1-3—CO—NR5R6, —(CHR7)1-3—CO—OR5, —(CH2)1-3—NR5R6, —(CH2)1-3—CO[NCHR7CO]mNH2 and —(CH2)1-3—CO[NCHR7CO]mOR5,
- n is an integer selected from 1 and 2;
- m is an integer selected from 1, 2 and 3;
- R5 and R6 are independently selected from —H, —C1-5 alkyl and —(CH2)0-3-aryl,
- R7 is selected from —H, —C1-5 alkyl, —(CH2)1-3-aryl and —(CH2)1-3-heteroaryl, such that when m is greater than 1 the R7 substituents can be equal to or different from one another,
- wherein the C1-5 alkyl, C2-5 alkenyl, cycloalkyl and heterocycle groups can be optionally substituted with one or several substituents selected independently from halogen, OH, OR5, OCF3, SH, SR5, NH2, NR5R6, NHCOR5;
- COOH, COOR5, OCOR5, aryl and heteroaryl,
- wherein the aryl and heteroaryl groups can be optionally substituted with one or several substituents selected independently from halogen, CF3, OH, ORS, OCF3, SH, SR5, NH2, NHCOR5;
- NO2, CN, COR5, COOR5, OCOR5, CONR5R6, —(CH2)0-3NR5R6, SO2NH2, NHSO2CH3, C1-5 alkyl, aryl and heteroaryl,
- wherein the heterocycle and heteroaryl groups can be optionally substituted on a secondary nitrogen atom with C1-5 alkyl, cycloalkyl or —(CH2)0-3-aryl,
- on the condition that when R2 is 2-(4-fluorophenyl)ethyl, R4 is —CH2—CO—NH2 and n is 1, then:
- if R1 is 2-(4-fluorophenyl)ethyl, R3 is not 2-(4-methoxyphenyl)ethyl, 2-(2-pyridyl)ethyl or 2-(2,4-dichlorophenyl)ethyl, and
- if R1 is 2-(2,4-dichlorophenyl)ethyl, R3 is not 2-(4-methoxyphenyl)ethyl or 2-(2-pyridyl)ethyl.
14 more elements
Dependencies are inferred from the claim text.